🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the recommended Phase IIa dose (RP2D) of the triplet combinati...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2024-12-31
Trial ID
NCT06683755
Treatments Being Tested
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Status
Unknown
Location
National University Hospital
Start Date
2019-02-21
Trial ID
NCT03784040
Treatments Being Tested
The CTLA-4 blocking monoclonal antibody ipilimumab (MDX-010, BMS-734016), h...
Status
Completed
Location
UZ Brussel
Start Date
2011-02
Trial ID
NCT01302496
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This phase I trial studies the side effects and best dose of ipilimumab and...
Status
Completed
Location
Yale University
Start Date
2012-12-14
Trial ID
NCT01757639
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of the combi...
Status
Completed
Location
St George's University Hospitals NHS Foundation Trust
Start Date
2018-10-04
Trial ID
NCT03711188
Treatments Being Tested
Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Status
Active Not Recruiting
Location
Duke Cancer Institute
Start Date
2020-01-01
Trial ID
NCT04013854
Treatments Being Tested
The purpose is to determine the safety, effectiveness and best dose to use ...
Status
Completed
Location
City Of Hope
Start Date
2012-02-09
Trial ID
NCT01472081
Treatments Being Tested
A one-arm, single center phase 2 trial of SAbR plus ipilimumab plus nivolum...
Status
Withdrawn
Location
University of Texas Southwestern Medical Center - Dallas
Start Date
2018-03-01
Trial ID
NCT03126461
Treatments Being Tested